Company intelligence / Profile preview

Clinical Network Services

Brisbane, Australia

Ownership: Private
Development stage: Other

Overview

Clinical Network Services (CNS) is an Australian full-service contract research organization (CRO), specializing in planning and management of Phase I and II clinical trials. CNS creates value for small/medium-sized biotech companies primarily by progressing early-stage products through Phase 1/2 trials, leveraging Australia/New Zealand’s regulatory environment for rapid clinic entry. CNS provides global product development and regulatory affairs consultancy via its BioDesk unit. In 2018, CNS was acquired by Novotech, a leading Asia-Pacific CRO.

Industry: Contract Research Organization

Partnerships

Novotech

Beyond the preview

Go deeper on Clinical Network Services.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Clinical Network Services.

Explore the full profile